Efficacy and Safety of Rivaroxaban, Apixaban, and Edoxaban for Nonvalvular Atrial Fibrillation Based on Blood Coagulation Activity and Drug Plasma Concentration: SETtsu and North-Osaka Multicenter Direct Oral AntiCoagulant (SET DOAC) Registry

Preprint

Article

This version is not peer-reviewed.

Downloads

188

Views

114

Comments

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.

Disclaimer